Mitochondrial iron and calcium homeostasis in Friedreich ataxia

IUBMB Life ◽  
2021 ◽  
Vol 73 (3) ◽  
pp. 543-553 ◽  
Author(s):  
Jordi Tamarit ◽  
Elena Britti ◽  
Fabien Delaspre ◽  
Marta Medina‐Carbonero ◽  
Arabela Sanz‐Alcázar ◽  
...  
genesis ◽  
2007 ◽  
Vol 45 (6) ◽  
pp. 339-352 ◽  
Author(s):  
Jennifer L. Peters ◽  
Jodi Dufner-Beattie ◽  
Wenhao Xu ◽  
Jim Geiser ◽  
Brett Lahner ◽  
...  

1999 ◽  
Vol 45 (5) ◽  
pp. 673-675 ◽  
Author(s):  
Martin B. Delatycki ◽  
James Camakaris ◽  
Hilary Brooks ◽  
Tracy Evans-Whipp ◽  
David R. Thorburn ◽  
...  

2008 ◽  
Vol 18 (1) ◽  
pp. 1-11 ◽  
Author(s):  
A. Campanella ◽  
E. Rovelli ◽  
P. Santambrogio ◽  
A. Cozzi ◽  
F. Taroni ◽  
...  

2012 ◽  
Vol 27 (9) ◽  
pp. 1212-1216 ◽  
Author(s):  
Robert B. Wilson

Friedreich ataxia is an inherited, severe, progressive neuro- and cardiodegenerative disorder for which there currently is no approved therapy. Friedreich ataxia is caused by the decreased expression and/or function of frataxin, a mitochondrial matrix protein that binds iron and is involved in the formation of iron-sulfur clusters. Decreased frataxin function leads to decreased iron-sulfur cluster formation, mitochondrial iron accumulation, cytosolic iron depletion, oxidative stress, and mitochondrial dysfunction. Cloning of the disease gene for Friedreich ataxia and elucidation of many aspects of the biochemical defects underlying the disorder have led to several major therapeutic initiatives aimed at increasing frataxin expression, reversing mitochondrial iron accumulation, and alleviating oxidative stress. These initiatives are in preclinical and clinical development and are reviewed herein.


1997 ◽  
Vol 17 (2) ◽  
pp. 215-217 ◽  
Author(s):  
Agnès Rötig ◽  
Pascale de Lonlay ◽  
Dominique Chretien ◽  
Françoise Foury ◽  
Michel Koenig ◽  
...  

2012 ◽  
Vol 109 (50) ◽  
pp. 20590-20595 ◽  
Author(s):  
M. Whitnall ◽  
Y. S. Rahmanto ◽  
M. L.- H. Huang ◽  
F. Saletta ◽  
H. C. Lok ◽  
...  

Blood ◽  
2007 ◽  
Vol 110 (1) ◽  
pp. 1-2 ◽  
Author(s):  
Grazia Isaya

Boddaert and colleagues show the positive effects of selective iron chelation in young patients with Friedreich ataxia, a devastating inborn error of mitochondrial iron metabolism.


Sign in / Sign up

Export Citation Format

Share Document